Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

CRIPT Inhibitors

CRIPT Inhibitors encompasses a diverse range of compounds designed to modulate the activity of CRIPT (CXXC Repeat Containing Interactor of PDZ3 Domain), a protein integral to the functioning and structure of neural synapses. These inhibitors are characterized by their varied approaches to influencing CRIPT's role in neuronal signaling and development. Predominantly, these compounds achieve their function by targeting the key cellular processes and signaling pathways with which CRIPT is associated. Their mechanisms include altering neuronal activity, modulating cell adhesion processes, influencing key intracellular signaling pathways, and affecting cellular growth and proliferation. By interacting with these pathways, CRIPT inhibitors can modify the function of CRIPT in synaptic organization and neuronal communication. The development and functionality of CRIPT inhibitors are grounded in the understanding that CRIPT's interaction with PDZ domain-containing proteins at synaptic sites is fundamental to its role in neuronal signaling. These inhibitors operate by either disrupting CRIPT's ability to interact with these proteins or by altering the downstream signaling cascades that CRIPT influences. This is achieved through various molecular mechanisms, such as kinase inhibition, alteration of intracellular ion concentrations, modulation of second messenger systems, and interference with key molecular pathways involved in neural development and synaptic plasticity. The diversity of these inhibitors reflects the complexity of CRIPT's interactions within the nervous system, highlighting the intricate network of molecular and cellular interactions essential for synaptic formation, maintenance, and function. In sum, CRIPT inhibitors represent a significant group of compounds that provide valuable insights into the molecular underpinnings of synaptic function and neural development. Their ability to affect key aspects of neural signaling and development underscores the critical role of CRIPT in these processes. As research tools, these inhibitors facilitate the exploration of the myriad functions of CRIPT, enhancing our understanding of neural communication and the molecular basis of synaptic organization. This class of inhibitors, therefore, plays a crucial role in advancing our knowledge of the fundamental mechanisms of neuronal function and synaptic dynamics.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 inhibits vacuolar-type H+-ATPase, and this action could possibly inhibit CRIPT's cell surface expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. Inhibiting the PI3K pathway could possibly inhibit CRIPT-mediated processes in neural development.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK in the MAPK/ERK pathway. Disrupting this pathway could possibly inhibit CRIPT's function in neural processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAP kinase, which could possibly inhibit CRIPT's role in neuronal development and response.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR. This inhibition could possibly inhibit CRIPT's role in neural development.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin modulates multiple signaling pathways and could possibly inhibit CRIPT's activity in neural cell adhesion and growth.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine inhibits the Hedgehog signaling pathway, which could possibly inhibit CRIPT's function in neural development.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

IWP-2 inhibits Wnt processing and secretion. This could possibly inhibit CRIPT's role in neural patterning.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

NSC23766 inhibits Rac1, a small GTPase involved in cytoskeletal rearrangements, which could possibly inhibit CRIPT's role in cell adhesion and migration.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium Chloride inhibits GSK-3β, which could possibly inhibit processes involving CRIPT, impacting Wnt signaling.